Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
15:58 | Synchron, Nvidia showcase AI for brain-computer interfaces | ||
14:58 | CARGO offloads staff after abandoning lead CAR-T | ||
13:58 | Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug | ||
12:58 | Gantenerumab 'shows sign of preventing Alzheimer's dementia' | ||
10:58 | UK is becoming an 'outlier' for pharma, hitting investment | ||
Mi | Roche taps Oxford BioTherapeutics for cancer drug discovery | ||
Mi | Google promises new AI models for drug discovery | ||
Mi | J&J's nipocalimab fast-tracked for Sjogren's disease | ||
Mi | Sarepta slumps on Elevidys patient death | ||
Mi | Novartis sheds staff as Entresto patent expiry looms | ||
Di | EnteroBiotix cues up larger trial of microbiome IBS therapy | ||
Di | Novo Nordisk returns to ABPI fold after two-year suspension | ||
Di | Sofinnova closes new fund and backs a trio of new biotechs | ||
Di | AstraZeneca buys cell therapy biotech for up to $1bn | ||
Di | Vertanical's cannabis-based painkiller hits target in trials | ||
Mo | Latigo raises $150m for non-opioid painkiller push | ||
Mo | Taiho snaps up ADC partner Araris for up to $1.14bn | ||
Mo | Eisai to buy "dementia ecosystem" partner EcoNaviSta | ||
Fr | FDA chooses flu vaccine strains despite cancelled meeting | ||
Fr | NHS England 'has lost control of health service', says BMA | ||
Fr | Pharma furious as UK Statutory Scheme rebate rate soars | ||
Fr | NHS England 'had lost control of health service', says BMA | ||
Fr | Sutro puts lead ADC on hold, cuts staff and changes CEO | ||
Fr | Third indication beckons for Amgen's Uplizna | ||
13.03. | Trump pulls CDC head nomination as FDA, CDC picks advance |